These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 23873857

  • 21. Impact of percutaneous femoral arteriotomy closure using the MANTATM device on vascular and bleeding complications after transcatheter aortic valve replacement.
    De Palma R, Settergren M, Rück A, Linder R, Saleh N.
    Catheter Cardiovasc Interv; 2018 Nov 01; 92(5):954-961. PubMed ID: 29575678
    [Abstract] [Full Text] [Related]

  • 22. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A.
    JACC Cardiovasc Interv; 2010 Nov 01; 3(11):1110-21. PubMed ID: 21087745
    [Abstract] [Full Text] [Related]

  • 23. A simple percutaneous technique for hemostasis and closure after transcatheter aortic valve implantation.
    Badawi RA, Collins TJ, Ramee SR.
    Catheter Cardiovasc Interv; 2012 Jan 01; 79(1):152-5. PubMed ID: 21990123
    [Abstract] [Full Text] [Related]

  • 24. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
    Pendyala LK, Minha S, Barbash IM, Torguson R, Magalhaes MA, Okubagzi P, Loh JP, Chen F, Satler LF, Pichard AD, Waksman R.
    Am J Cardiol; 2014 Jan 15; 113(2):342-7. PubMed ID: 24220281
    [Abstract] [Full Text] [Related]

  • 25. Use of an ePTFE-covered nitinol self-expanding stent graft for the treatment off pre-closure device failure during transcatheter aortic valve replacement.
    Steinvil A, Bernardo N, Rogers T, Koifman E, Buchanan K, Alraies MC, Shults C, Torguson R, Okubagzi PG, Pichard AD, Satler LF, Ben-Dor I, Waksman R.
    Cardiovasc Revasc Med; 2017 Mar 15; 18(2):128-132. PubMed ID: 27865711
    [Abstract] [Full Text] [Related]

  • 26. A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation.
    Buchanan GL, Chieffo A, Montorfano M, Maccagni D, Maisano F, Latib A, Covello RD, Grimaldi A, Alfieri O, Colombo A.
    Catheter Cardiovasc Interv; 2013 Mar 15; 81(4):579-83. PubMed ID: 22511470
    [Abstract] [Full Text] [Related]

  • 27. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F, Raffort J, Dommerc C, Benhammamia M, Bourlon F, Habib Y, Mialhe C.
    Vasc Endovascular Surg; 2017 Jul 15; 51(5):282-287. PubMed ID: 28474978
    [Abstract] [Full Text] [Related]

  • 28. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
    Abdel-Wahab M, Mehilli J, Frerker C, Neumann FJ, Kurz T, Tölg R, Zachow D, Guerra E, Massberg S, Schäfer U, El-Mawardy M, Richardt G, CHOICE investigators.
    JAMA; 2014 Apr 16; 311(15):1503-14. PubMed ID: 24682026
    [Abstract] [Full Text] [Related]

  • 29. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
    García E, Martín P, Hernández R, Rodríguez V, Fernández A, Gama V, Almería C, Macaya C.
    Catheter Cardiovasc Interv; 2014 Apr 01; 83(5):791-5. PubMed ID: 24285561
    [Abstract] [Full Text] [Related]

  • 30. Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Drafts BC, Choi CH, Sangal K, Cammarata MW, Applegate RJ, Gandhi SK, Kincaid EH, Kon N, Zhao DX.
    Catheter Cardiovasc Interv; 2018 Jun 01; 91(7):1354-1362. PubMed ID: 29024382
    [Abstract] [Full Text] [Related]

  • 31. The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement.
    Kiramijyan S, Magalhaes MA, Ben-Dor I, Koifman E, Escarcega RO, Baker NC, Torguson R, Okubagzi P, Bernardo NL, Satler LF, Pichard AD, Waksman R.
    EuroIntervention; 2016 May 17; 12(1):88-93. PubMed ID: 27173868
    [Abstract] [Full Text] [Related]

  • 32. A modified "preclosure" technique after percutaneous aortic valve replacement.
    Kahlert P, Eggebrecht H, Erbel R, Sack S.
    Catheter Cardiovasc Interv; 2008 Nov 15; 72(6):877-84. PubMed ID: 19006257
    [Abstract] [Full Text] [Related]

  • 33. Management of vascular complications following transcatheter aortic valve implantation.
    Perrin N, Ellenberger C, Licker M, Hachulla AL, Cikirikcioglu M, Frei A, Roffi M, Noble S.
    Arch Cardiovasc Dis; 2015 Oct 15; 108(10):491-501. PubMed ID: 26073229
    [Abstract] [Full Text] [Related]

  • 34. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J, Kahlert P, Neumann FJ, Schymik G, Webb JG, Amarenco P, Brott T, Garami Z, Gerosa G, Lefèvre T, Plicht B, Pocock SJ, Schlamann M, Thomas M, Diamond B, Merioua I, Beyersdorf F, Vahanian A.
    JACC Cardiovasc Interv; 2014 Oct 15; 7(10):1146-55. PubMed ID: 25341709
    [Abstract] [Full Text] [Related]

  • 35. The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States.
    Lardizabal JA, O'Neill BP, Desai HV, Macon CJ, Rodriguez AP, Martinez CA, Alfonso CE, Bilsker MS, Carillo RG, Cohen MG, Heldman AW, O'Neill WW, Williams DB.
    J Am Coll Cardiol; 2013 Jun 11; 61(23):2341-5. PubMed ID: 23583248
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Alternative access options for transcatheter aortic valve replacement in patients with no conventional access and chest pathology.
    Al Kindi AH, Salhab KF, Roselli EE, Kapadia S, Tuzcu EM, Svensson LG.
    J Thorac Cardiovasc Surg; 2014 Feb 11; 147(2):644-51. PubMed ID: 23537467
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
    Fink N, Segev A, Barbash I, Bogdan A, Hamdan A, Mazin I, Maor E, Hay I, Guetta V, Fefer P.
    Catheter Cardiovasc Interv; 2016 Feb 01; 87(2):341-6. PubMed ID: 26010839
    [Abstract] [Full Text] [Related]

  • 40. Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety.
    Mylotte D, Sudre A, Teiger E, Obadia JF, Lee M, Spence M, Khamis H, Al Nooryani A, Delhaye C, Amr G, Koussa M, Debry N, Piazza N, Modine T.
    JACC Cardiovasc Interv; 2016 Mar 14; 9(5):472-80. PubMed ID: 26965937
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.